Zealand Pharma A/S and OTR Therapeutics have entered into a strategic collaboration and license agreement aimed at discovering and developing novel therapies for metabolic diseases. The partnership combines Zealand Pharma’s expertise in obesity and metabolic health with OTR Therapeutics’ proprietary research platform and capabilities in drug discovery and development. The companies said the agreement will focus on creating next-generation therapeutics to expand treatment options for patients ...